Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CenteneLTS:0HVB 66 5-Year Share Buyback Ratio is 3.80 as of Jun. 2026. GuruFocus rates LTS:0HVB with a GF Score™ of 66/100 and a GF Value™ of $79.11 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 17 Healthcare Plans companies, Centene ranks better than 88.24% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Centene's current 5-Year Share Buyback Ratio was 3.80%.
LTS:0HVB's 5-Year Share Buyback Ratio is ranked better than 88.24% of 17
companies
in the Healthcare Plans industry
Industry Median: 0.9
vs LTS:0HVB: 3.80
Centene (LTS:0HVB) 5-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Centene 5-Year Share Buyback Ratio Related Terms
LTS:0HVB vs HUM, MOH, OSCR: 5-Year Share Buyback Ratio Comparison
For the Healthcare Plans subindustry, Centene's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centene 5-Year Share Buyback Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Centene's 5-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Centene's 5-Year Share Buyback Ratio falls into.
This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 5-Year Share Buyback Ratio of 3.80 mean?
Centene (LTS:0HVB) has a 5-Year Share Buyback Ratio of 3.80 as of Jun. 2026. The 5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. View historical data for Centene and its competitors. According to the industry distribution chart, Centene ranks #2 out of 17 companies in the Healthcare Plans industry, placing it in the top 11.8%.
Is Centene's 5-Year Share Buyback Ratio too high?
Centene's current 5-Year Share Buyback Ratio is 3.80. The Healthcare Plans industry median 5-Year Share Buyback Ratio is 0.90. Centene's value of 3.80 is 322.2% above this industry median. Based on the distribution chart, Centene ranks #2 out of 17 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Centene has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centene's 5-Year Share Buyback Ratio compare to HUM and MOH?
According to the Healthcare Plans industry distribution chart, Centene ranks #2 out of 17 companies for 5-Year Share Buyback Ratio. This places Centene in the top 12% of its industry — outperforming the majority of peers. The industry median 5-Year Share Buyback Ratio is 0.90. Centene's value of 3.80 is 322.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Share Buyback Ratio for a Healthcare Plans company?
The median 5-Year Share Buyback Ratio among Healthcare Plans companies is 0.90, based on 17 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Share Buyback Ratio significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centene's current 5-Year Share Buyback Ratio of 3.80 is 322.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Share Buyback Ratio mean?
A high 5-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. View historical data for Centene and its competitors. For the Healthcare Plans industry, the median 5-Year Share Buyback Ratio is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centene's current 5-Year Share Buyback Ratio is 3.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centene stock overvalued right now?
Based on GuruFocus' analysis, Centene (LTS:0HVB) is currently considered Modestly Undervalued. The stock's GF Value™ is $79.11, compared to a current price of $67.40 — trading 14.8% below its estimated fair value. The current 5-Year Share Buyback Ratio is 3.80 and 322.2% above the Healthcare Plans industry median of 0.90. Centene's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Share Buyback Ratio calculated?
5-Year Share Buyback Ratio is calculated from a company's financial statements. For Centene (LTS:0HVB), the current 5-Year Share Buyback Ratio is 3.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centene (LTS:0HVB) Overvalued in 2026?
Based on GuruFocus' analysis, Centene stock appears to be undervalued.
The current stock price of $67.40 is trading 14.8% below its estimated GF Value™ of $79.11.
GuruFocus considers Centene to be Modestly Undervalued.
Key valuation signals for LTS:0HVB:
5-Year Share Buyback Ratio: 3.80
GF Value™: $79.11 vs. price of $67.40 (14.8% below fair value)
Industry Position: 322.2% above the Healthcare Plans median (#2 of 17)
No single metric tells the full story. See the LTS:0HVB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
66GF Score
Get the complete analysis for LTS:0HVB
5-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0HVB has been successfully added to your 
